Biodefense and Government Contracting

BDO knows biodefense government contracting

Development of products, technologies, capabilities and facility expansion in the life science industry is capital intensive. 

Federal contracts can provide non-dilutive funding to life sciences companies and nonprofits developing products and technologies to address Chemical, Biological, Radiological or Nuclear (CBRN) threats, influenza and emerging infectious diseases.  

BDO’s Biodefense team affords clients a broad range of support to navigate the federal biodefense funding process: strategic guidance includes alignment with medical countermeasure priorities, technical advisement, project management, financial management and compliance services across the biodefense lifecycle. 

Our team has vast experience facilitating strategic partnerships between pharma/biotech and U.S. government agencies, including HHS Administration for Strategic Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA), National Institutes of Health (NIH), Defense Threat Reduction Agency (DTRA), DOD Medical CBRN Defense Consortium (MCDC), as well as experience engaging with federal audit agencies. This enables our Biodefense team to provide exceptional service to clients in identification of appropriate funding opportunities, engagement strategies and navigation of compliance requirements when working with the U.S. government.